Your session is about to expire
← Back to Search
CT-100-004-A Psoriasis for Psoriasis
Study Summary
This trial involves a platform called CT-100 that uses interactive software for therapeutic purposes. One type of component in CT-100 is called Digital Neuro-activation and Modulation (DiNaMo), which
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any available vacancies for potential participants in this research study?
"As per clinicaltrials.gov, this investigation is currently seeking participants. It was initially listed on 12/4/2023 and last revised on 2/16/2024."
How large is the participant pool for this clinical trial in its entirety?
"Affirmative. Details on clinicaltrials.gov show that recruitment is ongoing for this investigation. The trial was made public on December 4, 2023, with the latest update recorded on February 16, 2024. Enrollment of approximately 120 patients is targeted at a singular site."
What are the desired results that researchers hope to achieve through this investigation?
"The main focus of this research, assessed from Baseline to Week 4, is enhancing the overall assessment of improvement. Secondary goals encompass monitoring the occurrence and severity of both general adverse events as well as more severe ones throughout the study duration."
Share this study with friends
Copy Link
Messenger